Pharmacological alternatives to Antipsychotics in the Management of BPSD

2.50
Hdl Handle:
http://hdl.handle.net/2436/620682
Title:
Pharmacological alternatives to Antipsychotics in the Management of BPSD
Authors:
Reyad, Ayman Antoun
Abstract:
In this review, we will discuss the evidence and provide an update on the pharmacological treatments of Behavioural and Psychological symptoms of Dementia (BPSD) especially anti-psychotic medications. Non-pharmacological management of BPSD remains the initial treatment for BPSD; however, pharmacological management have a role in specific situations. This review should support the management of elderly inpatients suffering from Dementia and challenging behaviour in mental health units, general hospitals, community settings and care homes. It will help in raising awareness to the risk of complications such as stroke/death associated with first and second generation antipsychotic medications. It will also highlight some issues in relation to the current guidelines and licensing in the USA, UK and Europe. Good clinical practice used in the management of BPSD to reduce the risk of stroke and other complications is included.
Publisher:
Wiley
Journal:
Progress in Neurology and Psychiatry
Issue Date:
Jan-2018
URI:
http://hdl.handle.net/2436/620682
Additional Links:
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1931-227X
Type:
Article
Language:
en
ISSN:
1367-7543
Appears in Collections:
FEHW

Full metadata record

DC FieldValue Language
dc.contributor.authorReyad, Ayman Antounen
dc.date.accessioned2017-09-21T15:01:51Z-
dc.date.available2017-09-21T15:01:51Z-
dc.date.issued2018-01-
dc.identifier.issn1367-7543en
dc.identifier.urihttp://hdl.handle.net/2436/620682-
dc.description.abstractIn this review, we will discuss the evidence and provide an update on the pharmacological treatments of Behavioural and Psychological symptoms of Dementia (BPSD) especially anti-psychotic medications. Non-pharmacological management of BPSD remains the initial treatment for BPSD; however, pharmacological management have a role in specific situations. This review should support the management of elderly inpatients suffering from Dementia and challenging behaviour in mental health units, general hospitals, community settings and care homes. It will help in raising awareness to the risk of complications such as stroke/death associated with first and second generation antipsychotic medications. It will also highlight some issues in relation to the current guidelines and licensing in the USA, UK and Europe. Good clinical practice used in the management of BPSD to reduce the risk of stroke and other complications is included.en
dc.language.isoenen
dc.publisherWileyen
dc.relation.urlhttp://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1931-227Xen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBPSDen
dc.subjectantipsychoticsen
dc.subjectPharmacological managementen
dc.titlePharmacological alternatives to Antipsychotics in the Management of BPSDen
dc.typeArticleen
dc.identifier.journalProgress in Neurology and Psychiatryen
dc.date.accepted2017-07-
rioxxterms.funderInternalen
rioxxterms.identifier.projectUoW210917AARen
rioxxterms.versionAMen
rioxxterms.licenseref.urihttps://creativecommons.org/CC BY-NC-ND 4.0en
rioxxterms.licenseref.startdate2019-01-01en
This item is licensed under a Creative Commons License
Creative Commons
All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.